Search Results
The product title you are looking for is no longer available. Other similar products that may interest you are listed below:
| Title | Publication Date | Price | Relevance |
|---|---|---|---|
| R&D Trends: Breast Cancer - Innovative approaches target key signaling pathways in breast tumors Healthcare |
Jul 2011 | £2,405 | 100% |
| Innovations in Protein Kinase Therapies: Company pipelines, therapeutic applications and market forecasts | May 2009 | £2,425 | 99% |
| R&D Trends: Prostate Cancer Newly approved therapies shift treatment dynamics for castrate-resistant disease |
Jun 2011 | £2,405 | 98% |
| R&D Trends: Colorectal Cancer | Jun 2011 | £1,200 | 97% |
| Innovations In Epigenetics Advances in Technologies, Diagnostics & Therapeutics |
Nov 2009 | £2,425 | 97% |
| Drug Delivery in Cancer (2 pt) Technologies, Markets and Companies |
Jan 2012 | £2,590 | 96% |
| Innovations in Cancer Novel Therapeutics, New Diagnostics and Future R&D Strategies |
Feb 2007 | £1,820 | 96% |
| Cancer Therapies Global Market Opportunities |
Nov 2009 | £1,895 | 94% |
| Stakeholder Opinions: Gynecological Cancers Niche opportunities in advanced disease |
Dec 2006 | £2,400 | 92% |
| Drug Discovery and Preclinical Molecules by Therapy Area Innovation Focuses on Stem Cell Therapies and Gene Therapies |
Feb 2011 | £2,215 | 91% |
| Pipeline Insight: Colorectal Cancer Growing trend towards personalized medicine |
Oct 2009 | £7,210 | 91% |
| Pipeline Insight: Biologic Targeted Cancer Therapies Next generation jostles for market position |
Dec 2009 | £7,210 | 91% |
| CytRx Corporation – Product Pipeline Review H2 2011 |
Nov 2011 | £315 | 90% |
| Advancing Molecular Diagnostics to Personalize Cancer Therapy | Jun 2011 | £2,425 | 90% |
| Prostate Cancer Therapeutics | Apr 2009 | £2,500 | 90% |
| Advances in Apoptosis Research (Technical Insights) | Mar 2008 | £4,110 | 90% |
| Drug Targets for Breast Cancer | Jan 2006 | £1,095 | 90% |
| Non-small Cell Lung Cancer Drug Market in South Korea Targeted Therapies Offer Hope in Midst of Low Survival Rates and Increasing Incidence |
Aug 2011 | £6,325 | 90% |
| OncoVista Innovative Therapies, Inc. – Product Pipeline Review H2 2011 |
Dec 2011 | £315 | 89% |
| Lung Cancer Vaccines Pipeline, Strategies and Clinical |
Oct 2011 | £950 | 89% |
| Pipeline Insight: Small Molecule Targeted Cancer Therapies New targets set to drive growth |
Apr 2010 | £7,210 | 89% |
| Lung Cancer Therapeutic Antibodies Pipeline, Strategies and Clinical |
Oct 2011 | £750 | 89% |
| Geron Corporation – Product Pipeline Review H2 2011 |
Oct 2011 | £315 | 89% |
| Worldwide Cancer Market: Trend Analysis | Jun 2008 | £505 | 88% |
| Lung Cancer Vaccines and Therapeutic Antibodies | Oct 2011 | £1,490 | 88% |
| Antiviral Therapeutics Technologies, Markets and Companies |
Jan 2012 | £2,265 | 87% |
| Breast Cancer Therapeutic And Competitive Insights |
Feb 2007 | £1,295 | 87% |
| Cancer Cell Therapy Markets | Mar 2008 | £2,150 | 87% |
| U.S. Skin Cancer Market | Apr 2011 | £3,795 | 86% |
| Pain Therapeutics Technologies, Markets and Companies |
Jan 2012 | £2,590 | 86% |
